The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Polyoxazoline: Chemistry, Properties, and Applications in Drug Delivery
Abstract
Polyoxazoline polymers with methyl (PMOZ), ethyl (PEOZ), and propyl (PPOZ) side chains were prepared by the living cationic polymerization method and purified by ion-exchange chromatography. The following properties of polyoxazoline (POZ) were measured: apparent hydrodynamic radius by aqueous size-exclusion chromatography, relative lipophilicity by reverse-phase chromatography, and viscosity by cone-plate viscometry. The PEOZ polymers of different molecular weights were first functionalized and then conjugated to model biomolecules such as bovine serum albumin, catalase, ribonuclease, uricase, and insulin. The conjugates of catalase, uricase, and ribonuclease were tested for in vitro activity using substrate-specific reaction methods. The conjugates of insulin were tested for glucose lowering activity by injection to naïve Sprague-Dawley rats. The conjugates of BSA were injected into New Zealand white rabbits and serum samples were collected periodically and tested for antibodies to BSA. The safety of POZ was also determined by acute and chronic dosing to rats. The results showed that linear polymers of POZ with molecular weights of 1 to 40 kDa can easily be made with polydispersity values below 1.10. Chromatography results showed that PMOZ and PEOZ have a hydrodynamic volume slightly lower than PEG; PEOZ is more lipophilic than PMOZ and PEG; and PEOZ is significantly less viscous than PEG especially at the higher molecular weights. When PEOZ was attached to the enzymes catalase, ribonuclease, and uricase, the in vitro activity of the resultant bioconjugates depended on the extent of protein modification. POZ conjugates of insulin lowered blood glucose levels for a period of 8 h when compared to 2 h for insulin alone. PEOZ, like PEG, was also able to successfully attenuate the immunogenic properties of BSA. The POZ polymers (10 and 20 kDa) are safe when administered intravenously to rats, and the maximum tolerated dose (MTD) was greater than 2 g/kg. Blood counts, serum chemistry, organ weights, and the histopathology of key organs were normal. These results conclude that POZ has the desired drug delivery properties for a new biopolymer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SPECTROPHOTOMETRIC METHOD FOR MEASURING THE BREAKDOWN OF HYDROGEN PEROXIDE BY CATALASE
Beers, R. F., & Sizer, I. W. (1952) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50881-x · Cited by 6,761
Determination of free amino groups in proteins by trinitrobenzenesulfonic acid
Habeeb, A. F. S. A. (1966) · Analytical Biochemistry · doi:10.1016/0003-2697(66)90275-2 · Cited by 2,038
Poly(2‐oxazoline)s: A Polymer Class with Numerous Potential Applications
Hoogenboom, R. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200901607 · Cited by 889
Armstrong, J. K., Hempel, G., Koling, S., Chan, L. S., Fisher, T., Meiselman, H. J., & Garratty, G. (2007) · Cancer · doi:10.1002/cncr.22739 · Cited by 699
Poly(2-oxazolines) in biological and biomedical application contexts
Adams, N., & Schubert, U. S. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.018 · Cited by 492
Woodle, M. C., Engbers, C. M., & Zalipsky, S. (1994) · Bioconjugate Chemistry · doi:10.1021/bc00030a001 · Cited by 361
Poly-2-methyl-2-oxazoline: A Peptide-like Polymer for Protein-Repellent Surfaces
Konradi, R., Pidhatika, B., Mühlebach, A., & Textor, M. (2008) · Langmuir · doi:10.1021/la702917z · Cited by 354
Evaluation of Blood Clearance Rates and Biodistribution of Poly(2-oxazoline)-Grafted Liposomes§
Zalipsky, S., Hansen, C. B., Oaks, J. M., & Allen, T. M. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js9504043 · Cited by 314
PEG-uricase in the management of treatment-resistant gout and hyperuricemia
Sherman, M. R., Saifer, M. G. P., & Perez-Ruiz, F. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.011 · Cited by 291
Wiesbrock, F., Hoogenboom, R., Leenen, M. A. M., Meier, M. A. R., & Schubert, U. S. (2005) · Macromolecules · doi:10.1021/ma0474170 · Cited by 288
Cited by
Therapeutic Protein–Polymer Conjugates: Advancing Beyond PEGylation
Pelegri-O’Day, E. M., Lin, E.-W., & Maynard, H. D. (2014) · Journal of the American Chemical Society · doi:10.1021/ja504390x · Cited by 622
Shi, D., Beasock, D., Fessler, A., Szebeni, J., Ljubimova, J. Y., Afonin, K. A., & Dobrovolskaia, M. A. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114079 · Cited by 535
Poly (2-oxazoline) s as polymer therapeutics
Luxenhofer, R., Han, Y., Schulz, A., Tong, J., He, Z., Kabanov, A. V., & Jordan, R. (2012) · Macromolecular Rapid Communications · doi:10.1002/marc.201200354 · Cited by 470
Poly(2-oxazoline)s based biomaterials: a comprehensive and critical update
Lorson, T., Lübtow, M. M., Wegener, E., Haider, M. S., Borova, S., Nahm, D., Jordan, R., Sokolski-Papkov, M., Kabanov, A. V., & Luxenhofer, R. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.05.022 · Cited by 391
On the biodegradability of polyethylene glycol, polypeptoids and poly(2-oxazoline)s
Ulbricht, J., Jordan, R., & Luxenhofer, R. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.02.029 · Cited by 348
He, Z., Wan, X., Schulz, A., Bludau, H., Dobrovolskaia, M. A., Stern, S. T., Montgomery, S. A., Yuan, H., Li, Z., Alakhova, D., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.002 · Cited by 197
Protein–polymer conjugation — moving beyond PEGylation
Qi, Y., & Chilkoti, A. (2015) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2015.08.009 · Cited by 176
Tailored poly(2-oxazoline) polymer brushes to control protein adsorption and cell adhesion
Zhang, N., Pompe, T., Amin, I., Luxenhofer, R., Werner, C., & Jordan, R. (2012) · Macromolecular Bioscience · doi:10.1002/mabi.201200026 · Cited by 171
Drug-induced morphology switch in drug delivery systems based on poly(2-oxazoline)s
Schulz, A., Jaksch, S., Schubel, R., Wegener, E., Di, Z., Han, Y., Meister, A., Kressler, J., Kabanov, A. V., Luxenhofer, R., et al. (2014) · ACS Nano · doi:10.1021/nn406388t · Cited by 142
Han, Y., He, Z., Schulz, A., Bronich, T. K., Jordan, R., Luxenhofer, R., & Kabanov, A. V. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300159u · Cited by 125
POxylation as an alternative stealth coating for biomedical applications
Bludau, H., Czapar, A. E., Pitek, A. S., Shukla, S., Jordan, R., & Steinmetz, N. F. (2017) · European Polymer Journal · doi:10.1016/j.eurpolymj.2016.10.041 · Cited by 112
Gaspar, V. M., Gonçalves, C., de Melo-Diogo, D., Costa, E. C., Queiroz, J. A., Pichon, C., Sousa, F., & Correia, I. J. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.040 · Cited by 91
Mansfield, E. D. H., de la Rosa, V. R., Kowalczyk, R. M., Grillo, I., Hoogenboom, R., Sillence, K., Hole, P., Williams, A. C., & Khutoryanskiy, V. V. (2016) · Biomaterials Science · doi:10.1039/c6bm00375c · Cited by 75
Huesmann, D., Sevenich, A., Weber, B., & Barz, M. (2015) · Polymer · doi:10.1016/j.polymer.2015.04.070 · Cited by 67
Conjugation of hyaluronan to proteins
Mero, A., Pasqualin, M., Campisi, M., Renier, D., & Pasut, G. (2013) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2012.11.090 · Cited by 69
Self-citationSeo, Y., Schulz, A., Han, Y., He, Z., Bludau, H., Wan, X., Tong, J., Bronich, T. K., Sokolsky, M., Luxenhofer, R., et al. (2015) · Polymers for Advanced Technologies · doi:10.1002/pat.3556 · Cited by 67
Feng, H., Changez, M., Hong, K., Mays, J. W., & Kang, N.-G. (2017) · Macromolecules · doi:10.1021/acs.macromol.6b02084 · Cited by 30
Metadata
- Authors
- Viegas, T. X., Bentley, M. D., Harris, J. M., Fang, Z., Yoon, K., Dizman, B., Weimer, R., Mero, A., Pasut, G., & Veronese, F. M.
- Venue
- Bioconjugate Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2011-04-20
- Volume
- 22
- Issue
- 5
- Pages
- 976-986
- ISSN
- 1043-1802 (ISSN-L)
- 1520-4812
- OpenAlex
- W2317610963
- Cited by
- 432
- References
- 32
- FWCI
- 9.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.